HeartSciences Inc HSCS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Fortitude Appoints Kimberly Pittman as Chief Legal Officer
-
Fortitude Announces Amendment to Existing DCG Credit Facility, Increasing Commitment by $24 Million and Providing for Future Funding in ZEC
-
Fortitude Appoints Jaime Leverton as Chief Executive Officer
-
Fortitude Provides Second Quarter 2026 Financial and Operating Highlights
-
Fortitude Purchases 9,000 Bitmain Antminer Z15 Pro Units, Deepening Commitment to the Zcash Ecosystem
Trading Information
- Previous Close Price
- $3.89
- Day Range
- $3.87–4.44
- 52-Week Range
- $1.63–5.25
- Bid/Ask
- $4.40 / $4.81
- Shares Outstanding
- 4.84M
- Market Cap
- $20.83M
- Volume/Avg
- 110 / 111,202
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 3,060.50
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare setting, either via the MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via the MyoVista wavECG Device.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 14
- Website
- https://www.heartsciences.com
Valuation
|
Metric
|
HSCS
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 3,060.50 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
HSCS
|
|---|---|
Quick Ratio | 0.01 |
Current Ratio | 0.14 |
Interest Coverage | −11.75 |
Quick Ratio
HSCS
Profitability
|
Metric
|
HSCS
|
|---|---|
Return on Assets (Normalized) | −144.59% |
Return on Equity (Normalized) | −513.37% |
Return on Invested Capital (Normalized) | −166.18% |
Return on Assets
HSCS
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|TKr%$#k | LOCK|G%BwJ | $169B | |||
| Medtronic PLC
MDT
| LOCK|?y$@h!k | LOCK|&mKZ | $110B | |||
| Stryker Corp
SYK
| LOCK|$c$@>W< | LOCK|%!G | $106B | |||
| Boston Scientific Corp
BSX
| LOCK|@jW%s?w | LOCK|M$cc& | $62B | |||
| Edwards Lifesciences Corp
EW
| LOCK|HmVyL!v | LOCK|zTV> | $49B | |||
| DexCom Inc
DXCM
| LOCK|Bh&&W&!> | LOCK|FJMd? | $32B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|f#^B&l^ | LOCK|cRj | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|L@ | LOCK|?N | $23B | |||
| Steris PLC
STE
| LOCK|!?HZ^J$ | LOCK|g^G? | $20B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|Hb?N%?k | LOCK|#DZ | $17B |
United States